Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Third Point, Sarissa Capital, Citadel LLC, Point72 Asset Management, Kinder Morgan Inc (KMI), Cyclerion Therapeutics Inc (CYCN), and More

Insiders Swarming Over Kinder Morgan Stock – Here’s Why (Seeking Alpha)
Heavy insider buying often represents an unequivocal “Buy” signal in the stock market. Over the past few months, CEO Richard Kinder has purchased over 3.0 million shares of Kinder Morgan stock. The move signals a large vote of confidence in the business on the part of executives. Income hunters should take note. If you ever wanted an unequivocal “Buy” signal in dividend investing, it would be heavy insider purchases.

The VP, Secretary & Gen. Counsel of Cintas Corp (NASDAQ: CTAS) is Selling Shares (AnalystRatings)
Today, the VP, Secretary & Gen. Counsel of Cintas Corp (CTAS), Thomas Frooman, sold shares of CTAS for $501.9K. Following Thomas Frooman’s last CTAS Sell transaction on February 15, 2019, the stock climbed by 3.6%. Based on Cintas Corp’s latest earnings report for the quarter ending February 28, the company posted quarterly revenue of $1.68 billion and quarterly net profit of $203 million. In comparison, last year the company earned revenue of $1.59 billion and had a net profit of $290 million. CTAS’s market cap is $21.76B and the company has a P/E ratio of 27.25. Currently, Cintas Corp has an average volume of 119.6K.

Thursday 4/4 Insider Buying Report: CYCN, ELGX (
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy – they expect to make money. So let’s look at two noteworthy recent insider buys. And on Wednesday, Director Thomas F. Zenty III bought $19,995 worth of Endologix, buying 3,025 shares at a cost of $6.61 each. Endologix is trading up about 1.1% on the day Thursday. So far Zenty III is in the green, up about 8.9% on their purchase based on today’s trading high of $7.20.

Cyclerion Therapeutics Inc (NASDAQ:CYCN) Insider Trading Activity – President Bought 270,107 shares of Stock (MarketExclusive)
Insider Trading Activity For Cyclerion Therapeutics Inc (NASDAQ:CYCN): Mark G Currie , President of Cyclerion Therapeutics Inc (NASDAQ:CYCN) reportedly Bought 270,107 shares of the company’s stock at an average price of 14.81 for a total transaction amount of $4,000,284.67.

Insiders Bullish on Certain Holdings of MDYV (
A look at the weighted underlying holdings of the SPDR S&P 400 Mid Cap Value ETF (MDYV) shows an impressive 15.5% of holdings on a weighted basis have experienced insider buying within the past six months. Caesars Entertainment Corp (Symbol: CZR), which makes up 0.58% of the SPDR S&P 400 Mid Cap Value ETF ( MDYV ), has seen 4 directors and officers purchase shares in the past six months, according to the recent Form 4 data.